Compare Cadila Healthcare with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs J.B.CHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES J.B.CHEMICALS ZYDUS LIFESCIENCES/
J.B.CHEMICALS
 
P/E (TTM) x 15.9 30.2 52.5% View Chart
P/BV x 2.9 6.7 42.6% View Chart
Dividend Yield % 1.0 1.0 92.0%  

Financials

 ZYDUS LIFESCIENCES   J.B.CHEMICALS
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-21
J.B.CHEMICALS
Mar-21
ZYDUS LIFESCIENCES/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs5091,318 38.6%   
Low Rs259443 58.4%   
Sales per share (Unadj.) Rs147.5264.3 55.8%  
Earnings per share (Unadj.) Rs20.958.0 36.0%  
Cash flow per share (Unadj.) Rs28.066.9 41.8%  
Dividends per share (Unadj.) Rs3.5016.50 21.2%  
Avg Dividend yield %0.91.9 48.6%  
Book value per share (Unadj.) Rs126.9234.2 54.2%  
Shares outstanding (eoy) m1,023.7477.28 1,324.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.63.3 78.1%   
Avg P/E ratio x18.415.2 121.2%  
P/CF ratio (eoy) x13.713.2 104.4%  
Price / Book Value ratio x3.03.8 80.5%  
Dividend payout %16.828.4 59.0%   
Avg Mkt Cap Rs m393,09268,043 577.7%   
No. of employees `000NANA-   
Total wages/salary Rs m22,5483,406 662.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m151,02220,425 739.4%  
Other income Rs m4491,166 38.5%   
Total revenues Rs m151,47121,591 701.5%   
Gross profit Rs m31,3355,562 563.4%  
Depreciation Rs m7,248687 1,055.5%   
Interest Rs m1,68872 2,331.2%   
Profit before tax Rs m22,8485,969 382.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4721,484 99.2%   
Profit after tax Rs m21,3764,485 476.6%  
Gross profit margin %20.727.2 76.2%  
Effective tax rate %6.424.9 25.9%   
Net profit margin %14.222.0 64.5%  
BALANCE SHEET DATA
Current assets Rs m87,16018,939 460.2%   
Current liabilities Rs m78,6136,866 1,145.0%   
Net working cap to sales %5.759.1 9.6%  
Current ratio x1.12.8 40.2%  
Inventory Days Days33122 27.2%  
Debtors Days Days76695 10.9%  
Net fixed assets Rs m140,9436,786 2,077.1%   
Share capital Rs m1,024155 662.5%   
"Free" reserves Rs m128,89917,943 718.4%   
Net worth Rs m129,92318,097 717.9%   
Long term debt Rs m6,0950-   
Total assets Rs m228,10325,725 886.7%  
Interest coverage x14.583.4 17.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 83.4%   
Return on assets %10.117.7 57.1%  
Return on equity %16.524.8 66.4%  
Return on capital %18.033.4 54.0%  
Exports to sales %00-   
Imports to sales %10.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,911NA-   
Fx inflow Rs m63,5359,082 699.6%   
Fx outflow Rs m15,9111,792 887.8%   
Net fx Rs m47,6247,290 653.3%   
CASH FLOW
From Operations Rs m32,9303,148 1,046.1%  
From Investments Rs m-7,225-2,307 313.2%  
From Financial Activity Rs m-25,489-874 2,915.6%  
Net Cashflow Rs m-905-33 2,760.8%  

Share Holding

Indian Promoters % 74.9 0.0 -  
Foreign collaborators % 0.0 54.0 -  
Indian inst/Mut Fund % 15.4 26.1 59.1%  
FIIs % 2.5 9.2 27.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 46.0 54.6%  
Shareholders   408,017 61,314 665.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    AUROBINDO PHARMA    



Today's Market

SGX Nifty Trades Flat, Maruti Suzuki Acquires Stake in AI Firm, Zomato Q4 Results, and Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets failed to keep up early gains and ended marginally lower.

Related Views on News

Cadila Healthcare Reports 73% Rise in Profits (Views On News)

May 28, 2021

A look into the company's quarter four financial performance.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZYDUS LIFESCIENCES SHARE PRICE


May 23, 2022 (Close)

TRACK ZYDUS LIFESCIENCES

  • Track your investment in ZYDUS LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZYDUS LIFESCIENCES

ZYDUS LIFESCIENCES - ZOTA HEALTH CARE COMPARISON

COMPARE ZYDUS LIFESCIENCES WITH

MARKET STATS